BioRegen Biomedical (Changzhou) Co., Ltd.
PrivateLast Round
IPO
Jul 3, 2026
Total Funding Raised
$7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioRegen Biomedical (Changzhou) Co., Ltd. operates in Healthcare & Life Sciences and is based in Changzhou. Its latest recorded funding round was a Strategic round in February 2021.
BioRegen Biomedical (Changzhou) Co., Ltd. is a medical device company that develops and manufactures therapeutic biomaterials and regenerative medicine products, including hyaluronic acid-based gels for surgical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioRegen Biomedical (Changzhou) Co., Ltd. Comparables
Compare BioRegen Biomedical (Changzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Bestlife Regenerative Medicine Technology Co., Ltd. | 88% | |
| Beijing Datsing Bio-Tech Co., Ltd. | 83% | |
| Hangzhou Singclean Medical Products Co., Ltd. | 82% |
For institutional investors. Book with your work email.
BioRegen Biomedical (Changzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 3, 2026 | ||||
| Strategic | Feb 1, 2021 | ||||
| Series D | Jun 1, 2016 | ||||
| Series C | Jun 7, 2013 | ||||
| Series B | Jan 1, 2011 | ||||
Series A | Dec 1, 2008 |
For institutional investors. Book with your work email.
BioRegen Biomedical (Changzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orient Securities Capital Investment Company | Strategic |
| F-Prime Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
$15.14M raised in IPO round.
- Apr 11, 2026
Grew 57% QoQ from 7 to 11 employees.
For institutional investors. Book with your work email.
BioRegen Biomedical (Changzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioRegen Biomedical (Changzhou) Co., Ltd.'s valuation, stock price, and market status.
Is BioRegen Biomedical (Changzhou) Co., Ltd. a public or private company?
BioRegen Biomedical (Changzhou) Co., Ltd. is a private company.
What is the current stock price of BioRegen Biomedical (Changzhou) Co., Ltd.?
BioRegen Biomedical (Changzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks BioRegen Biomedical (Changzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioRegen Biomedical (Changzhou) Co., Ltd. worth (valuation)?
Valuation information for BioRegen Biomedical (Changzhou) Co., Ltd. is not publicly available.
Can I buy BioRegen Biomedical (Changzhou) Co., Ltd. stock?
BioRegen Biomedical (Changzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioRegen Biomedical (Changzhou) Co., Ltd.'s last funding round?
BioRegen Biomedical (Changzhou) Co., Ltd.'s most recent funding round was IPO on July 3, 2026.
Who are the main investors in BioRegen Biomedical (Changzhou) Co., Ltd.?
Key investors in BioRegen Biomedical (Changzhou) Co., Ltd. include Orient Securities Capital Investment Company, F-Prime Capital.
Will BioRegen Biomedical (Changzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for BioRegen Biomedical (Changzhou) Co., Ltd..
How can I track BioRegen Biomedical (Changzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in BioRegen Biomedical (Changzhou) Co., Ltd.'s shares on secondary markets.